Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Marquis, Miriam"" wg kryterium: Autor


Wyświetlanie 1-13 z 13
Tytuł :
Cost-Effectiveness Analysis of a HMGA2 Prognostic Test for Acute Myeloid Leukemia in a Canadian Setting.
Autorzy :
Tremblay G; Purple Squirrel Economics, New York, NY, USA. .; Geneconomics Inc, 1372 rue Du crépuscule, Lévis, QC, Canada, G7A 4K3. .
Rousseau B; Adelphi Values, Bollington, UK.
Marquis M; The Leucegene Project, Université de Montréal, Montreal, QC, Canada.; Quebec Leukemia Cell Bank, Research Centre, Maisonneuve-Rosemont Hospital, 5415 l'Assomption Blvd, Montreal, QC, H1T 2M4, Canada.
Beaubois C; The Leucegene Project, Université de Montréal, Montreal, QC, Canada.; Quebec Leukemia Cell Bank, Research Centre, Maisonneuve-Rosemont Hospital, 5415 l'Assomption Blvd, Montreal, QC, H1T 2M4, Canada.
Sauvageau G; The Leucegene Project, Université de Montréal, Montreal, QC, Canada.; Quebec Leukemia Cell Bank, Research Centre, Maisonneuve-Rosemont Hospital, 5415 l'Assomption Blvd, Montreal, QC, H1T 2M4, Canada.; Division of Hematology-Oncology, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada.; Department of Medicine, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada.
Hébert J; The Leucegene Project, Université de Montréal, Montreal, QC, Canada. .; Quebec Leukemia Cell Bank, Research Centre, Maisonneuve-Rosemont Hospital, 5415 l'Assomption Blvd, Montreal, QC, H1T 2M4, Canada. .; Division of Hematology-Oncology, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada. .; Department of Medicine, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada. .
Pokaż więcej
Źródło :
Applied health economics and health policy [Appl Health Econ Health Policy] 2019 Dec; Vol. 17 (6), pp. 827-839.
Typ publikacji :
Journal Article
MeSH Terms :
Cost-Benefit Analysis*
Diagnostic Techniques and Procedures/*economics
HMGA2 Protein/*analysis
Leukemia, Myeloid, Acute/*diagnosis
Leukemia, Myeloid, Acute/*physiopathology
Biomarkers/analysis ; Canada ; Humans ; Leukemia, Myeloid, Acute/therapy ; Prognosis ; Quality-Adjusted Life Years
Czasopismo naukowe
Tytuł :
Correction: High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemia.
Autorzy :
Marquis M; The Quebec Leukemia Cell Bank, Research Centre, Maisonneuve-Rosemont Hospital, Montréal, Canada.; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada.
Beaubois C; The Quebec Leukemia Cell Bank, Research Centre, Maisonneuve-Rosemont Hospital, Montréal, Canada.; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada.
Lavallée VP; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada.; Division of Hematology-Oncology, Maisonneuve-Rosemont Hospital, Montréal, Canada.
Abrahamowicz M; Epidemiology and Biostatistics Department, McGill University, Montréal, Canada.
Danieli C; Epidemiology and Biostatistics Department, McGill University, Montréal, Canada.
Lemieux S; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada.; Department of Computer Science and Operations Research, Université de Montréal, Montréal, Canada.
Ahmad I; Division of Hematology-Oncology, Maisonneuve-Rosemont Hospital, Montréal, Canada.; Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, Canada.
Wei A; Department of Haematology, Alfred Hospital, Melbourne, Australia.; Australian Centre for Blood Diseases, Monash University, Melbourne, Australia.; Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia.
Ting SB; Australian Centre for Blood Diseases, Monash University, Melbourne, Australia.; Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia.; Department of Haematology, Eastern Health, Box Hill Hospital, Melbourne, Australia.
Fleming S; Department of Haematology, Alfred Hospital, Melbourne, Australia.
Schwarer A; Department of Haematology, Eastern Health, Box Hill Hospital, Melbourne, Australia.
Grimwade D; Cancer Genetics Laboratory, Department of Medical and Molecular Genetics, King's College London, London, UK.; UK National Cancer Research Institute (NCRI) Haematological Oncology Clinical Studies Group, Cardiff, UK.
Grey W; Cancer Genetics Laboratory, Department of Medical and Molecular Genetics, King's College London, London, UK.
Hills RK; UK National Cancer Research Institute (NCRI) Haematological Oncology Clinical Studies Group, Cardiff, UK.; Centre for Trials Research, Cardiff University School of Medicine, Cardiff, UK.
Vyas P; MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine and Department of Haematology, University of Oxford and Oxford University Hospitals NHS Trust, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Russell N; UK National Cancer Research Institute (NCRI) Haematological Oncology Clinical Studies Group, Cardiff, UK.; Centre for Clinical Haematology, Nottingham University Hospital (City Hospital Campus), Nottingham, UK.
Sauvageau G; The Quebec Leukemia Cell Bank, Research Centre, Maisonneuve-Rosemont Hospital, Montréal, Canada.; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada.; Division of Hematology-Oncology, Maisonneuve-Rosemont Hospital, Montréal, Canada.; Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, Canada.
Hébert J; The Quebec Leukemia Cell Bank, Research Centre, Maisonneuve-Rosemont Hospital, Montréal, Canada. .; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada. .; Division of Hematology-Oncology, Maisonneuve-Rosemont Hospital, Montréal, Canada. .; Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, Canada. .
Pokaż więcej
Źródło :
Blood cancer journal [Blood Cancer J] 2019 Feb 28; Vol. 9 (3), pp. 28. Date of Electronic Publication: 2019 Feb 28.
Typ publikacji :
Published Erratum
Tytuł :
High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemia.
Autorzy :
Marquis M; The Quebec Leukemia Cell Bank, Research Centre, Maisonneuve-Rosemont Hospital, Montréal, Canada.; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada.
Beaubois C; The Quebec Leukemia Cell Bank, Research Centre, Maisonneuve-Rosemont Hospital, Montréal, Canada.; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada.
Lavallée VP; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada.; Division of Hematology-Oncology, Maisonneuve-Rosemont Hospital, Montréal, Canada.
Abrahamowicz M; Epidemiology and Biostatistics Department, McGill University, Montréal, Canada.
Danieli C; Epidemiology and Biostatistics Department, McGill University, Montréal, Canada.
Lemieux S; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada.; Department of Computer Science and Operations Research, Université de Montréal, Montréal, Canada.
Ahmad I; Division of Hematology-Oncology, Maisonneuve-Rosemont Hospital, Montréal, Canada.; Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, Canada.
Wei A; Department of Haematology, Alfred Hospital, Melbourne, Australia.; Australian Centre for Blood Diseases, Monash University, Melbourne, Australia.; Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia.
Ting SB; Australian Centre for Blood Diseases, Monash University, Melbourne, Australia.; Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia.; Department of Haematology, Eastern Health, Box Hill Hospital, Melbourne, Australia.
Fleming S; Department of Haematology, Alfred Hospital, Melbourne, Australia.
Schwarer A; Department of Haematology, Eastern Health, Box Hill Hospital, Melbourne, Australia.
Grimwade D; Cancer Genetics Laboratory, Department of Medical and Molecular Genetics, King's College London, London, UK.; UK National Cancer Research Institute (NCRI) Haematological Oncology Clinical Studies Group, Cardiff, UK.
Grey W; Cancer Genetics Laboratory, Department of Medical and Molecular Genetics, King's College London, London, UK.
Hills RK; UK National Cancer Research Institute (NCRI) Haematological Oncology Clinical Studies Group, Cardiff, UK.; Centre for Trials Research, Cardiff University School of Medicine, Cardiff, UK.
Vyas P; MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine and Department of Haematology, University of Oxford and Oxford University Hospitals NHS Trust, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Russell N; UK National Cancer Research Institute (NCRI) Haematological Oncology Clinical Studies Group, Cardiff, UK.; Centre for Clinical Haematology, Nottingham University Hospital (City Hospital Campus), Nottingham, UK.
Sauvageau G; The Quebec Leukemia Cell Bank, Research Centre, Maisonneuve-Rosemont Hospital, Montréal, Canada.; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada.; Division of Hematology-Oncology, Maisonneuve-Rosemont Hospital, Montréal, Canada.; Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, Canada.
Hébert J; The Quebec Leukemia Cell Bank, Research Centre, Maisonneuve-Rosemont Hospital, Montréal, Canada. .; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada. .; Division of Hematology-Oncology, Maisonneuve-Rosemont Hospital, Montréal, Canada. .; Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, Canada. .
Pokaż więcej
Źródło :
Blood cancer journal [Blood Cancer J] 2018 Jul 19; Vol. 8 (8), pp. 68. Date of Electronic Publication: 2018 Jul 19.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Transcriptomic landscape of acute promyelocytic leukemia reveals aberrant surface expression of the platelet aggregation agonist Podoplanin.
Autorzy :
Lavallée VP; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec, Canada.; Division of Hematology, Hôpital Maisonneuve-Rosemont, Montréal, Canada.
Chagraoui J; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec, Canada.
MacRae T; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec, Canada.
Marquis M; Quebec Leukemia Cell Bank, Hôpital Maisonneuve-Rosemont, Montréal, Canada.
Bonnefoy A; Department of Medicine, Université de Montréal, Montréal, Canada.; Centre Hospitalier Universitaire Sainte-Justine, Montréal, Canada.
Krosl J; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec, Canada.
Lemieux S; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec, Canada.; Division of Hematology, Hôpital Maisonneuve-Rosemont, Montréal, Canada.; Quebec Leukemia Cell Bank, Hôpital Maisonneuve-Rosemont, Montréal, Canada.; Department of Medicine, Université de Montréal, Montréal, Canada.; Centre Hospitalier Universitaire Sainte-Justine, Montréal, Canada.; Department of Computer Science and Operations Research, Université de Montréal, Montréal, Canada.
Marinier A; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec, Canada.; Division of Hematology, Hôpital Maisonneuve-Rosemont, Montréal, Canada.; Quebec Leukemia Cell Bank, Hôpital Maisonneuve-Rosemont, Montréal, Canada.; Department of Medicine, Université de Montréal, Montréal, Canada.; Centre Hospitalier Universitaire Sainte-Justine, Montréal, Canada.; Department of Computer Science and Operations Research, Université de Montréal, Montréal, Canada.; Department of Chemistry, Université de Montréal, Montréal, Canada.
Pabst C; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec, Canada.
Rivard GÉ; Department of Medicine, Université de Montréal, Montréal, Canada.; Centre Hospitalier Universitaire Sainte-Justine, Montréal, Canada.
Hébert J; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec, Canada. .; Division of Hematology, Hôpital Maisonneuve-Rosemont, Montréal, Canada. .; Quebec Leukemia Cell Bank, Hôpital Maisonneuve-Rosemont, Montréal, Canada. .; Department of Medicine, Université de Montréal, Montréal, Canada. .
Sauvageau G; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec, Canada. .; Division of Hematology, Hôpital Maisonneuve-Rosemont, Montréal, Canada. .; Quebec Leukemia Cell Bank, Hôpital Maisonneuve-Rosemont, Montréal, Canada. .; Department of Medicine, Université de Montréal, Montréal, Canada. .
Pokaż więcej
Źródło :
Leukemia [Leukemia] 2018 Jun; Vol. 32 (6), pp. 1349-1357. Date of Electronic Publication: 2018 Feb 23.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Transcriptome*
Hemorrhage/*etiology
Leukemia, Promyelocytic, Acute/*complications
Membrane Glycoproteins/*physiology
Adult ; Aged ; Animals ; Female ; Flow Cytometry ; Humans ; Leukemia, Promyelocytic, Acute/genetics ; Male ; Membrane Glycoproteins/genetics ; Mice ; Middle Aged ; Platelet Aggregation ; Thrombocytopenia/etiology ; Tretinoin/pharmacology
Czasopismo naukowe
Tytuł :
The atypical MAPK ERK3 controls positive selection of thymocytes.
Autorzy :
Sirois J; Maisonneuve-Rosemont Hospital Research Centre, Montreal, QC, Canada; Department of Microbiology, Infection and Immunology, University of Montreal, Montreal, QC, Canada.
Daudelin JF
Boulet S
Marquis M
Meloche S
Labrecque N
Pokaż więcej
Źródło :
Immunology [Immunology] 2015 May; Vol. 145 (1), pp. 161-9.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Clonal Selection, Antigen-Mediated*
MAP Kinase Signaling System/*immunology
Mitogen-Activated Protein Kinase 6/*immunology
Receptors, Antigen, T-Cell/*immunology
T-Lymphocytes/*immunology
Thymocytes/*immunology
Thymus Gland/*immunology
Animals ; Gene Expression Regulation, Enzymologic/genetics ; Gene Expression Regulation, Enzymologic/immunology ; MAP Kinase Signaling System/genetics ; Mice ; Mice, Knockout ; Mitogen-Activated Protein Kinase 3/genetics ; Mitogen-Activated Protein Kinase 3/immunology ; Mitogen-Activated Protein Kinase 6/genetics ; Receptors, Antigen, T-Cell/genetics ; T-Lymphocytes/cytology ; Thymocytes/cytology ; Thymus Gland/cytology
Czasopismo naukowe
Tytuł :
The catalytic activity of the mitogen-activated protein kinase extracellular signal-regulated kinase 3 is required to sustain CD4+ CD8+ thymocyte survival.
Autorzy :
Marquis M; Maisonneuve-Rosemont Hospital Research Centre, Montreal, Quebec, Canada Department of Microbiology, Infectiology and Immunology, University of Montreal, Montreal, Quebec, Canada.
Daudelin JF; Maisonneuve-Rosemont Hospital Research Centre, Montreal, Quebec, Canada.
Boulet S; Maisonneuve-Rosemont Hospital Research Centre, Montreal, Quebec, Canada.
Sirois J; Maisonneuve-Rosemont Hospital Research Centre, Montreal, Quebec, Canada Department of Microbiology, Infectiology and Immunology, University of Montreal, Montreal, Quebec, Canada.
Crain K; Maisonneuve-Rosemont Hospital Research Centre, Montreal, Quebec, Canada.
Mathien S; Program in Molecular Biology, University of Montreal, Montreal, Quebec, Canada Institute of Research in Immunology and Cancer, University of Montreal, Montreal, Quebec, Canada.
Turgeon B; Program in Molecular Biology, University of Montreal, Montreal, Quebec, Canada Institute of Research in Immunology and Cancer, University of Montreal, Montreal, Quebec, Canada.
Rousseau J; Program in Molecular Biology, University of Montreal, Montreal, Quebec, Canada Institute of Research in Immunology and Cancer, University of Montreal, Montreal, Quebec, Canada.
Meloche S; Department of Pharmacology, University of Montreal, Montreal, Quebec, Canada Program in Molecular Biology, University of Montreal, Montreal, Quebec, Canada .
Labrecque N; Maisonneuve-Rosemont Hospital Research Centre, Montreal, Quebec, Canada Department of Microbiology, Infectiology and Immunology, University of Montreal, Montreal, Quebec, Canada Department of Medicine, University of Montreal, Montreal, Quebec, Canada .
Pokaż więcej
Źródło :
Molecular and cellular biology [Mol Cell Biol] 2014 Sep 15; Vol. 34 (18), pp. 3374-87. Date of Electronic Publication: 2014 Jul 07.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
CD4-Positive T-Lymphocytes/*immunology
CD8-Positive T-Lymphocytes/*immunology
Mitogen-Activated Protein Kinase 6/*genetics
Mitogen-Activated Protein Kinase 6/*metabolism
Thymocytes/*cytology
Thymus Gland/*cytology
Animals ; Animals, Newborn ; CD4-Positive T-Lymphocytes/enzymology ; CD8-Positive T-Lymphocytes/enzymology ; Catalytic Domain ; Cell Differentiation/genetics ; Cell Proliferation ; Cell Survival ; Embryo, Mammalian ; Gene Knock-In Techniques ; Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor ; Mice ; Mice, Inbred C57BL ; Mice, Transgenic ; Thymocytes/immunology
Czasopismo naukowe
Tytuł :
The non-classical MAP kinase ERK3 controls T cell activation.
Autorzy :
Marquis M; Maisonneuve-Rosemont Hospital Research Centre, Montreal, Quebec, Canada ; Department of Microbiology, Infectiology and Immunology, University of Montreal, Quebec, Canada.
Boulet S; Maisonneuve-Rosemont Hospital Research Centre, Montreal, Quebec, Canada.
Mathien S; Institute of Research in Immunology and Cancer, University of Montreal, Quebec, Canada.
Rousseau J; Department of Pharmacology and Molecular Biology, University of Montreal, Quebec, Canada ; Institute of Research in Immunology and Cancer, University of Montreal, Quebec, Canada.
Thébault P; Maisonneuve-Rosemont Hospital Research Centre, Montreal, Quebec, Canada.
Daudelin JF; Maisonneuve-Rosemont Hospital Research Centre, Montreal, Quebec, Canada.
Rooney J; Maisonneuve-Rosemont Hospital Research Centre, Montreal, Quebec, Canada.
Turgeon B; Department of Pharmacology and Molecular Biology, University of Montreal, Quebec, Canada ; Institute of Research in Immunology and Cancer, University of Montreal, Quebec, Canada.
Beauchamp C; Maisonneuve-Rosemont Hospital Research Centre, Montreal, Quebec, Canada.
Meloche S; Department of Pharmacology and Molecular Biology, University of Montreal, Quebec, Canada ; Institute of Research in Immunology and Cancer, University of Montreal, Quebec, Canada.
Labrecque N; Maisonneuve-Rosemont Hospital Research Centre, Montreal, Quebec, Canada ; Department of Microbiology, Infectiology and Immunology, University of Montreal, Quebec, Canada ; Department of Medicine, University of Montreal, Quebec, Canada.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2014 Jan 27; Vol. 9 (1), pp. e86681. Date of Electronic Publication: 2014 Jan 27 (Print Publication: 2014).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Gene Expression Regulation/*immunology
Immunity, Cellular/*immunology
Lymphocyte Activation/*immunology
Mitogen-Activated Protein Kinase 6/*metabolism
T-Lymphocytes/*immunology
Animals ; Cell Proliferation ; Cytokines/metabolism ; DNA Primers/genetics ; Flow Cytometry ; Immunoblotting ; Immunoprecipitation ; Mice ; Mitogen-Activated Protein Kinase 6/deficiency ; Reverse Transcriptase Polymerase Chain Reaction ; T-Lymphocytes/metabolism ; beta-Galactosidase
Czasopismo naukowe
Tytuł :
Oritavancin does not induce Clostridium difficile germination and toxin production in hamsters or a human gut model.
Autorzy :
Freeman J; Department of Microbiology, Leeds Teaching Hospitals NHS Trust, The General Infirmary, Old Medical School, Leeds LS1 3EX, UK.
Marquis M
Crowther GS
Todhunter SL
Fawley WN
Chilton CH
Moeck G
Lehoux D
Wilcox MH
Pokaż więcej
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2012 Dec; Vol. 67 (12), pp. 2919-26. Date of Electronic Publication: 2012 Aug 16.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-Bacterial Agents/*metabolism
Bacterial Toxins/*biosynthesis
Clostridioides difficile/*drug effects
Clostridioides difficile/*growth & development
Glycopeptides/*metabolism
Spores, Bacterial/*drug effects
Spores, Bacterial/*growth & development
Aged ; Aged, 80 and over ; Animals ; Bacterial Load ; Cecum/chemistry ; Cecum/microbiology ; Clostridium Infections/microbiology ; Clostridium Infections/pathology ; Cricetinae ; Disease Models, Animal ; Feces/chemistry ; Feces/microbiology ; Humans ; Lipoglycopeptides ; Vancomycin/metabolism
Czasopismo naukowe
Tytuł :
Selective expression of human immunodeficiency virus Nef in specific immune cell populations of transgenic mice is associated with distinct AIDS-like phenotypes.
Autorzy :
Hanna Z; Laboratory of Molecular Biology, Clinical Research Institute of Montreal, 110 Pine Avenue West, Montreal, Quebec H2W 1R7, Canada. />Priceputu E
Chrobak P
Hu C
Dugas V
Goupil M
Marquis M
de Repentigny L
Jolicoeur P
Pokaż więcej
Źródło :
Journal of virology [J Virol] 2009 Oct; Vol. 83 (19), pp. 9743-58. Date of Electronic Publication: 2009 Jul 15.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Gene Expression Regulation, Viral*
Acquired Immunodeficiency Syndrome/*virology
nef Gene Products, Human Immunodeficiency Virus/*metabolism
Animals ; Antigens, CD/biosynthesis ; Antigens, Differentiation, Myelomonocytic/biosynthesis ; CD11c Antigen/biosynthesis ; CD4 Antigens/biosynthesis ; CD4-Positive T-Lymphocytes/virology ; Cell Separation ; Dendritic Cells/virology ; Disease Models, Animal ; Humans ; Macrophages/virology ; Mice ; Mice, Transgenic
Czasopismo naukowe
Tytuł :
Overexpression of IL-21 promotes massive CD8+ memory T cell accumulation.
Autorzy :
Allard EL; Maisonneuve-Rosemont Hospital Research Centre, University of Montreal, Montreal, Canada.
Hardy MP
Leignadier J
Marquis M
Rooney J
Lehoux D
Labrecque N
Pokaż więcej
Źródło :
European journal of immunology [Eur J Immunol] 2007 Nov; Vol. 37 (11), pp. 3069-77.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunologic Memory*
CD8-Positive T-Lymphocytes/*metabolism
Interleukins/*metabolism
T-Lymphocyte Subsets/*metabolism
Animals ; CD8-Positive T-Lymphocytes/immunology ; Flow Cytometry ; Interleukin-7/immunology ; Interleukin-7/metabolism ; Interleukins/immunology ; Mice ; Mice, Transgenic ; Receptors, Interleukin-7/immunology ; Receptors, Interleukin-7/metabolism ; T-Lymphocyte Subsets/immunology
Czasopismo naukowe
Tytuł :
IL-21 promotes T lymphocyte survival by activating the phosphatidylinositol-3 kinase signaling cascade.
Autorzy :
Ostiguy V; Department of Medicine, Maisonneuve-Rosemont Hospital Research Center, 5415 boul. de l'Assomption, University of Montreal, Montreal, Quebec, Canada HIT 2M4.
Allard EL
Marquis M
Leignadier J
Labrecque N
Pokaż więcej
Źródło :
Journal of leukocyte biology [J Leukoc Biol] 2007 Sep; Vol. 82 (3), pp. 645-56. Date of Electronic Publication: 2007 Jun 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cell Survival/*drug effects
Interleukins/*pharmacology
Phosphatidylinositol 3-Kinases/*metabolism
T-Lymphocytes/*cytology
Animals ; Blotting, Western ; Cell Size ; Enzyme Activation ; Flow Cytometry ; Interleukin-21 Receptor alpha Subunit/genetics ; Interleukin-21 Receptor alpha Subunit/metabolism ; Lymphocyte Activation ; Mice ; Mice, Inbred C57BL ; Phosphorylation ; Proto-Oncogene Proteins c-bcl-2/genetics ; Proto-Oncogene Proteins c-bcl-2/metabolism ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Receptors, Antigen, T-Cell, alpha-beta/genetics ; Receptors, Antigen, T-Cell, alpha-beta/physiology ; Reverse Transcriptase Polymerase Chain Reaction ; Signal Transduction ; T-Lymphocytes/metabolism
Czasopismo naukowe
Tytuł :
Altered CD4+ T cell phenotype and function determine the susceptibility to mucosal candidiasis in transgenic mice expressing HIV-1.
Autorzy :
Lewandowski D; Department of Microbiology and Immunology, Sainte-Justine Hospital, 3175 Côte Ste-Catherine, Montreal, Quebec H3T 1C5, Canada.
Marquis M
Aumont F
Lussier-Morin AC
Raymond M
Sénéchal S
Hanna Z
Jolicoeur P
de Repentigny L
Pokaż więcej
Źródło :
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2006 Jul 01; Vol. 177 (1), pp. 479-91.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Genetic Predisposition to Disease*
Immunophenotyping*
CD4-Positive T-Lymphocytes/*immunology
Candidiasis/*genetics
Candidiasis/*immunology
HIV-1/*genetics
HIV-1/*immunology
Mouth Mucosa/*immunology
Adoptive Transfer ; Animals ; CD4-Positive T-Lymphocytes/microbiology ; CD4-Positive T-Lymphocytes/transplantation ; CD4-Positive T-Lymphocytes/virology ; CD8-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/microbiology ; CD8-Positive T-Lymphocytes/virology ; Candida albicans/immunology ; Candidiasis/pathology ; Candidiasis/virology ; Cell Proliferation ; Coculture Techniques ; Cytokines/biosynthesis ; Dendritic Cells/immunology ; Dendritic Cells/microbiology ; Dendritic Cells/transplantation ; Dendritic Cells/virology ; Female ; HIV Infections/genetics ; HIV Infections/immunology ; HIV Infections/microbiology ; HIV Infections/pathology ; Immunity, Mucosal/genetics ; Immunologic Memory/genetics ; Lymph Nodes/immunology ; Lymph Nodes/microbiology ; Lymph Nodes/pathology ; Lymph Nodes/virology ; Lymphocyte Activation/genetics ; Male ; Mice ; Mice, Inbred C3H ; Mice, Transgenic ; Mouth Mucosa/microbiology ; Mouth Mucosa/virology ; Neck ; Phagocytosis/genetics ; Phagocytosis/immunology
Czasopismo naukowe
Tytuł :
CD8+ T cells but not polymorphonuclear leukocytes are required to limit chronic oral carriage of Candida albicans in transgenic mice expressing human immunodeficiency virus type 1.
Autorzy :
Marquis M; Department of Microbiology and Immunology, Sainte-Justine Hospital and University of Montreal, 3175 Côte Ste-Catherine, Montreal, Quebec H3T 1C5, Canada.
Lewandowski D
Dugas V
Aumont F
Sénéchal S
Jolicoeur P
Hanna Z
de Repentigny L
Pokaż więcej
Źródło :
Infection and immunity [Infect Immun] 2006 Apr; Vol. 74 (4), pp. 2382-91.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
CD8-Positive T-Lymphocytes/*immunology
CD8-Positive T-Lymphocytes/*microbiology
Candida albicans/*immunology
Candidiasis, Oral/*immunology
HIV Infections/*immunology
HIV-1/*genetics
Neutrophils/*immunology
Neutrophils/*microbiology
Animals ; CD4 Antigens/genetics ; CD8 Antigens/genetics ; CD8-Positive T-Lymphocytes/virology ; Candidiasis, Oral/genetics ; Candidiasis, Oral/virology ; Cells, Cultured ; Chronic Disease ; Disease Models, Animal ; Female ; HIV Infections/genetics ; HIV Infections/microbiology ; Humans ; Leukopenia/genetics ; Leukopenia/immunology ; Male ; Mice ; Mice, Inbred C3H ; Mice, Knockout ; Mice, Transgenic ; Neutrophils/virology ; Phagocytosis/genetics ; Respiratory Burst/genetics ; Time Factors
Czasopismo naukowe
    Wyświetlanie 1-13 z 13

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies